Requirement of MyD88 for macrophage-mediated islet xenograft rejection after adoptive transfer

Transplantation

Volumn 83, Issue 5, 2007, Pages 615-623

  Yi, Shounan ^a,c   Wang, Ying ^a   Chandra, Abhilash P ^a   O'Hara, Jennifer M ^a   Wu, Jingjing ^a   Ouyang, Li ^a   Burgess, Jane S ^a   Hawthorne, Wayne ^a   Wu, Huiling ^b   Chadban, Steven J ^b   O'Connell, Philip J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

Cellular activation; Macrophages; Toll like receptors; Xenotransplantation

Indexed keywords

MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELL ISOLATION; CELL TRANSPLANTATION; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; MACROPHAGE; MACROPHAGE ACTIVATION; NEWBORN; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

ADOPTIVE TRANSFER; ANIMALS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GRAFT REJECTION; ISLETS OF LANGERHANS TRANSPLANTATION; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; POLYMERASE CHAIN REACTION; SWINE; TOLL-LIKE RECEPTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 33947309224     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000253759.87886.39     Document Type: Article

References (41)

1. Pierson III RN, Winn HL, Russell PS, Auchincloss H Jr. Xenogeneic skin graft rejection is especially dependent on CD4+ T cells. J Exp Med 1989; 170: 991.
2. Morris CF, Simeonovic CJ, Fung MC, et al. Intragraft expression of cytokine transcripts during pig proislet xenograft rejection and tolerance in mice. J Immunol 1995; 154: 2470.
3. Loudovaris T, Mandel TE, Charlton B. CD4+ T-cell mediated destruction of xenografts within cell-impermeable membranes in the absence of CD8+ T cells and B cells. Transplantation 1996; 61: 1678.
4. Fox A, Mountford J, Braakhuis A, Harrison LC. Innate and adaptive immune responses to nonvascular xenografts: evidence that macrophages are direct effectors of xenograft rejection. J Immunol 2001; 166: 2133.
5. Yi S, Hawthorne WJ, Lehnert AM, et al. T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts. J Immunol 2003; 170: 2750.
6. Yi S, Ouyang L, Ha H, et al. Involvement of CCR5 signaling in macrophage recruitment to porcine islet xenografts. Transplantation 2005; 80: 1468.
7. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406: 782.
8. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675.
9. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20: 197.
10. Beutler B, Jiang Z, Georgel P, et al. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol 2006; 24: 353.
11. Schmitz F, Mages J, Heit A, et al. Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression profiling to a model of TLR signaling. Eu J Immunol 2004; 34: 2863.
12. Shi S, Nathan C, Chnappinger D, et al. MyD88 primes macrophages for full-scale activation by interferon-γ yet mediates few responses to mycobacterium tuberculosis. J Exp Med 2003; 198: 987.
13. Schnare M, Barton GM, Holt AC, et al. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001; 2: 947.
14. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1: 135.
15. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999; 11: 115.
16. Anderson CF, Mosser DM. A novel phenotype for an activated macrophage: the type a activated macrophage. J Leukoc Biol 2002; 72: 101.
17. Takeuchi O, Kaufmann A, Grote K, et al. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J Immunol 2000; 164: 554.
18. Bjorkbacka H, Kunjathoor VV, Moore KJ, et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 2004; 10: 416.
19. Chandra AP, Ouyang L, Yi S, et al. Chemokine and toll-like receptor signaling in macrophage mediated islet xenograft rejection. Xenotransplantation; Xenotransplantation 2007; 14: 48.
20. Adachi O, Kawai T, Takeda K, et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998; 9: 143.
21. Korbutt GS, Elliot JF, Ao Z, et al. Large scale isolation, growth, and function of porcine neonatal islet cells. J Clin Invest 1996; 97: 2119.
22. Lehnert AM, Yi S, Burgess JS, O'Connell PJ. Pancreatic islet xenograft tolerance after short-term costimulatory blockade is associated with increased CD4+ T cell apoptosis but not immune deviation. Transplantation 2000; 69: 1176.
23. Xia D, Sanders A, Shah M, et al. Real-time polymerase chain reaction analysis reveals an evolution of cytokinemRNAproduction in allograft acceptor mice. Transplantation 2001; 72: 907.
24. Goldstein DR, Tesar BM, Akira S, Lakkis FG. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 2003; 111: 1571.
25. Schmidt P, Krook H, Goto M, Korsgren O. MyD88-dependent toll-like receptor signaling is not a requirement for fetal islet xenograft rejection in mice. Xenotransplantation 2004; 11: 347.
26. Jamieson AM, Diefenbach A, McMahon CW, et al. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 2002; 17: 19.
27. Sandberg JO, Benda B, Lycke N, Korsgren O. Xenograft rejection of porcine islet-like cell clusters in normal, interferon-gamma, and interferon-gamma receptor deficient mice. Transplantation 1997; 63: 1446.
28. Johnson GB, Brunn GJ, Kodaira Y, Platt JL. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 2002; 168: 5233.
29. Li M, Carpio DF, Zheng Y, et al. An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissuerepair gene expression by necrotic cells. J Immunol 2001; 166: 7128.
30. Ohashi K, Burkarr V, Flohe S, Kolb H. Cutting edge: Heat shock protein 60 is a putative endogenous ligand of toll-like receptor-4 complex. J Immunol 2000; 164: 558.
31. Guillot L, Balloy V, McCormark FX, et al. Cutting edge: The immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J Immunol 2002; 168: 5989.
32. Hamerman JA, Ogasawara K, Lanier LL. Cutting edge: Toll-like recelptor signaling in macrophages induces ligands for the NKG2D receptor. J Immunol 2004; 172: 2001.
33. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17: 1.
34. Horng T, Barton GM, Medzhitov R. TiRAP: an adapter molecule in the Toll signaling pathway. Nat Immunol 2001; 2: 835.
35. Fitzgerald KA, Palsson-McDemott EM, Bowie AG, et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 2001; 413: 78.
36. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001; 19: 423.
37. Gerdes N, Sukhova GK, Libby P, et al. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 2002; 195: 245.
38. Gysemans C, Stoffels K, Giulietti A, et al. Prevention of primary non-function of islet xenografts in autoimmune diabeticNODmice by anti-inflammatory agents. Diabetologia 2003; 46: 1115.
39. Methe H, Zimmer E, Grimm C, et al. Evidence for a role of toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation. Transplantation 2004; 78: 1324.
40. Goldstein DR. Toll-like receptors and other links between innate and acquired alloimmunity. Curr Opi Immunol 2004; 16: 538.
41. Simeonovic CJ, Ziolkowski AF, Popp SK, et al. Porcine endogenous retrovirus encodes xenoantigens involved in porcine cellular xenograft rejection by mice. Transplantation 2005; 79: 1674.